Brody Lab

University of Michigan at Ann Arbor

PHARMACOLOGY

Ann Arbor · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

Defining the cardiomyocyte microdomain signaling landscape in cardiac hypertrophy

Abstract Heart disease is the leading cause of death globally and poses an enormous public health and economic burden. In the United States, prevalence and mortality due to heart failure have even increased in recent years, underscoring the need for a greater understanding of pathophysiological signaling mechanisms that underlie cardiac maladaptation. The cardiac myocyte is a highly specialized cell-type with a complex and unique cytoarchitectural landscape. However, mechanisms that topologically orient intracellular signaling events in cardiomyocytes remain ill-defined. While the roles of phosphorylation in cardiac signal transduction have been studied for decades, very little is known…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at University of Michigan at Ann Arbor